Position in AZN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$432,604,946
-$15,276,349 QoQ
Shares Held
2,281,431
+0.5% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#62
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $6,826,194,566 across 15 Drug Manufacturers - General names. AZN ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,175,866 | $1,410,369,073 | |
| 2 | JNJ |
Johnson & Johnson
|
4,910,996 | $1,247,245,654 | |
| 3 | ABBV |
AbbVie Inc.
|
4,886,670 | $1,229,681,638 | |
| 4 | AMGN |
Amgen Inc
|
1,689,843 | $611,925,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,996,890 | $513,600,365 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,281,431 | $432,604,946 | |
| 7 | NVS |
Novartis AG
|
2,330,979 | $365,311,028 | |
| 8 | PFE |
Pfizer Inc
|
9,513,242 | $229,078,867 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,604,946 | 2,281,431 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $447,881,295 | 2,270,973 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||